TLR2 activation led to increased NF-κB expression and secretion of the chemokine CCL2. Activation of TLR2 was confirmed by pre-treating cells with blocking antibodies to TLR2 prior to EBV infection. The gene discussed is TLR2; the disease is Epstein-Barr virus infection.